SCHEMBL7689595

SCHEMBL7689595

N#Cc1c(S)nc2ccccc2c1Nc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 9/20 0.57
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 4/20 0.44
RAD52 P43351 3/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
RAF1 P04049 1/20 0.44
MAP2K1 Q02750 1/20 0.44
POLB P06746 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GFER P55789 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7689600 0.76 ALDH1A1 (0.51) KDM1AKDM4EALDH1A1KMT2AADORA2A
SCHEMBL28613370 0.75 KDM1A (0.49) KDM1AKDM4EALDH1A1KMT2ARAD52
SCHEMBL7999923 0.75 KDM1A (0.49) KDM1AKDM4EALDH1A1KMT2ARAD52
SCHEMBL28618474 0.74 ALDH1A1 (0.50) KDM1AKDM4EALDH1A1KMT2ARAD52
SCHEMBL902770 0.74 KDM1A (1.00) KDM1AKDM4EKMT2ARAD52POLB
SCHEMBL4557943 0.73 KDM1A (0.47) KDM1AKDM4EALDH1A1KMT2ARAD52
SCHEMBL7845566 0.73 KDM1A (0.47) KDM1AKDM4EALDH1A1KMT2ARAD52
SCHEMBL17154430 0.73 KDM1A (0.68) KDM1AKDM4EKMT2ARAD52POLB
SCHEMBL7826829 0.73 KDM1A (0.43) KDM1AKDM4EALDH1A1KMT2ARAD52
Hydrochloric Acid SCHEMBL15673452 0.73 KDM1A (0.96) KDM1AKDM4EKMT2ARAD52POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020026052-A1 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2002-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020026052-A1 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors PKD1, PKD2, CSNK1A1 KDM1A 1536/4885KDM4E 1875/4885ALDH1A1 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.